High Purity Peptides Powder Mazdutide Semaglutide Tirzepatide CAS 2259884-03-0 Peptides Powder Mazdutide 2259884-03-0
5 Inquiries
2259884-03-0
Pharmaceutical Grade
99%
GUANGZHOU
MINGHENG
5mg/10mg/15mg/20mg/30mg per vial
Yes
2026-02-25
Tirzepatide,Retatrutide,Peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Basic Info-
Product Name:
Mazdutide
Other Name:Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)
CAS No.:2259884-03-0
Molecular Weight:0
EC Number:884-103-0
Color/Form:White to off-white
Categories:
Research-
Class:
Dual GLP-1R/GCGR agonist (long-acting peptide)
Status:Investigational — Phase 3 (China)
Mechanism:A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves.
EC50 (GLP1R Ki):28.6 nM
EC50 (GCGR Ki):17.7 nM
Source:GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI
Clinical Development:
References-
PubChem:Literature:
GlpBio: Mazdutide (CAS 2259884-03-0); eClinicalMedicine: Innovent Phase Ib results (2022); ClinicalTrials.gov: DREAMS-1 (NCT04930343)
Disclaimer:Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Peptides
-
Location:
Shop No. 47, Jixin Plaza, No. 26 Renmin Avenue, Renmin Street, Meilan District, Haikou City, Hainan Province
-
Payment Terms:
L/C,O/A,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2019
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mazdutide
25 MG Aug 12, 2026
Nigeria
Mazdutide 10mg
20 PCS Mar 7, 2026
United States
Mazdutide
30 MG Jul 15, 2024
United Kingdom
Mazdutide
1 KG Feb 10, 2026
United States
Mazddultide cas
2 MT Nov 14, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Beauty 99% Purity Blue Copper Ghk-Cu Copper Peptide Powder 49557-75-7
Pharmaceutical Grade / 99%
-
-
-
-
LL37 10mg Vials CAS 307297-39-8 Peptides Supply Ghk-Cu Retatrutide
Pharmaceutical Grade / 99%
-
-
-
-
High quality latest batch of teriparatide CAS 12583-68-5 at favorable price
Pharmaceutical Grade / 99%
-
-
-
-
High Quality Growth Hormone-Inhibiting Hormone CAS 51110-01-1 Somatostatin with wholesale price
Pharmaceutical Grade / 99%
-
-
-
-
Epithalon 10mg Vials Epitalon 307297-39-8 Peptides Supply Ghk-Cu Retatrutide
Pharmaceutical Grade / 99%
-
-
-
-
Hot Selling high Purity Peptide Nicotinamide Adenine Dinucleotide 53-84-9 Nad/ Nad+
Pharmaceutical Grade / 99%
-